Supplementation of 20 mL of PJ concentrate/day for one week resulted in a significant decrease of 11% in plasma lipid peroxidation, compared to plasma animal study obtained prior to PJ consumption. Supplementation of 50 mL PJ concentrate/day for one more week exhibited a further 21% decrease in plasma lipid peroxidation. However, a further increase in the supplemented PJ to 80 mL of PJ concentrate/day for an additional one week did not further inhibit plasma

susceptibility to lipid peroxidation. Gradual decreasing of the PJ dosage in these three subjects down to 40 mL/day for one week, and then to 20 mL/day for an additional two weeks, did not significantly affect plasma lipid peroxidation, which remained low in Inhibitors,research,lifescience,medical comparison to the levels obtained after supplementation of 80 mL of PJ concentrate/day.

Two weeks after cessation of PJ supplementation the reduced rate of plasma susceptibility to lipid peroxidation was sustained. After a further four weeks with no PJ consumption, plasma Inhibitors,research,lifescience,medical lipid peroxidation returned to the higher values obtained before PJ consumption.18 The effect of PJ consumption by patients with CAS on their serum oxidative state was also measured.12 A significant (P<0.01) reduction in the concentration of antibodies Inhibitors,research,lifescience,medical against Ox-LDL by 24% and 19% was observed after 1 and 3 months of PJ consumption, respectively (from 2070±61 EU/mL before treatment to 1563±69 and 1670±52 Inhibitors,research,lifescience,medical EU/mL after 1 and 3 months of PJ consumption, respectively). TAS in serum from these patients was substantially increased 2.3-fold (from 0.95±0.12 nmol/L at baseline, up to 2.20±0.25 nmol/L after 12 months of PJ consumption). These results indicate that PJ administration to patients with CAS substantially reduced their serum oxidative status and

could thus inhibit plasma lipid peroxidation. The susceptibility of the patients’ serum to free radical-induced oxidation decreased after 12 months of PJ consumption by up to 62% (Figure 2A). Increased oxidative inhibitor Y-27632 stress was observed in the serum of non-insulin-dependent Inhibitors,research,lifescience,medical type 2 diabetes mellitus patients versus healthy subjects (Figure 2B). Consumption of 50mL of PJ per day for a period of 3 months resulted in a significant reduction in the basal serum thiobarbituric Dacomitinib acid reactive substances (TBARS) levels, by 28% (Figure 2B).19 Consumption of PJ for 1 and 2 weeks by healthy volunteers increased the resistance of their LDL to copper ion-induced oxidation, as shown by a prolongation of the lag time required for the initiation of LDL oxidation, by 29% and 43%, in comparison to LDL obtained prior to juice consumption. Similarly, the resistance of their HDL to copper ion-induced oxidation also gradually increased after PJ consumption, as shown by a prolongation in the lag time required for the initiation of HDL oxidation from 37±2 minutes to 45±6 minutes before and 2 weeks after PJ consumption, respectively.